<DOC>
	<DOCNO>NCT01913470</DOCNO>
	<brief_summary>Non-alcoholic fatty liver disease ( NAFLD ) common liver disease among child closely associate obesity metabolic syndrome . NAFLD increase risk mortality natural history study adults show NAFLD independent risk factor cardiovascular disease . Pediatric NAFLD particularly concern public health standpoint , represent early possibly aggressive form disease . Currently effective treatment pediatric NAFLD . Losartan orally-administered angiotensin II receptor antagonist currently market treat high blood pressure . The renin-angiotensin-aldosterone ( RAA ) system show important many disease state include renal disease , cardiovascular disease , NAFLD . Angiotensin antagonists class medication propose novel treatment NAFLD part would treat factor increase cardiovascular ( CVD ) risk well potentially improve steatosis , fibrosis hepatic inflammation . This study randomize , double-blinded , placebo-controlled pilot study evaluate whether 8 week Losartan decrease inflammatory marker among child age 12-19 current diagnosis NAFLD . Efficacy assess improvement alanine aminotransferase ( ALT ) baseline . Secondary endpoint include aspartate aminotransferase ( AST ) , cytokeratin 18 level , fast triglyceride level among others . Safety assess record adverse event , clinical laboratory parameter , vital sign physical examination .</brief_summary>
	<brief_title>Study Losartan Treatment NAFLD Children</brief_title>
	<detailed_description />
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<criteria>• Age 12 19 year enrollment Body Mass Index ( BMI ) &gt; 85th % age gender History definite borderline NASH ( histology ) use NASH Clinical Research Network ( CRN ) criterion At least 3 month attempt lifestyle change liver biopsy ALT ≥ 3 time normal ( 69 U/L girl , 78 U/L boy ) enrollment • Other chronic illness require daily medication Supplement antioxidant therapy within past 4 week Renal insufficiency Cirrhosis liver synthetic dysfunction ( International Normalized Ratio &gt; 1.5 ) History hypotension Diabetes ( fast glucose &gt; 125 mg/dL ) Acute illness within past 2 week prior enrollment ( fever &gt; 100.4ºF ) Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>19 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>NAFLD</keyword>
	<keyword>Non-alcoholic Fatty Liver Disease</keyword>
	<keyword>Obesity</keyword>
	<keyword>Pediatrics</keyword>
	<keyword>Children</keyword>
	<keyword>Losartan</keyword>
	<keyword>Cozaar</keyword>
</DOC>